Electronic Patient Reporting of Symptoms During Cancer Treatment

Completed · Not applicable

Conditions studied: Metastatic Cancer

In brief

The current study is designed to test nationally whether patients' outcomes and utilization of services can be improved through symptom monitoring via patient-reported outcomes between visits.

Key facts

Study ID

NCT03249090

Run by

Alliance Foundation Trials, LLC.

People needed

1197

Starts

2017-10-30

Expected to finish

2023-08-30

Last updated by the study team

2025-01-14

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Adults (21+) with metastatic cancer of any type (EXCEPT leukemia or indolent [slow growing] lymphoma)
• Receiving outpatient systemic cancer treatment for non-curative/palliative intent, including chemotherapy, targeted therapy, or immunotherapy.
• Enrolled at any point in their treatment trajectory, meaning during any line of treatment, and at any point during a course or cycle of treatment.
• Can understand English, Spanish, and/or Mandarin Chinese.

You may not qualify if…

• Cognitive deficits that would preclude understanding of consent form and/or questionnaires.
• Current participation in a therapeutic clinical trial (because these often involve PRO questionnaires and intensive monitoring).
• Patients being treated with curative intent (e.g., adjuvant chemotherapy for breast, lung, or ovarian cancer; primary curative therapy for testis cancer or lymphoma).
• Receiving hormonal therapy only (e.g., tamoxifen or aromatase inhibitors in breast cancer; androgen deprivation therapy in prostate cancer; or octreotide in neuroendocrine cancers)
• Indolent lymphomas (due to their prolonged time courses that may be minimally symptomatic).
• Leukemias (time courses inconsistent with other tumor types in chronic and acute leukemias).
• Does not understand English, Spanish, or Mandarin Chinese.

Where it is running

• Grand Valley Oncology — Grand Junction, Colorado, United States
• Gwinnett Medical Center — Lawrenceville, Georgia, United States
• Ingalls Memorial Hospital — Harvey, Illinois, United States
• Illinois CancerCare-Peoria — Peoria, Illinois, United States
• Quincy Medical Group — Quincy, Illinois, United States
• Carle Cancer Center — Urbana, Illinois, United States
• Franciscan Health Indianapolis — Indianapolis, Indiana, United States
• Memorial Hospital of South Bend — South Bend, Indiana, United States
• Union Hospital — Terre Haute, Indiana, United States
• University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa, United States
• Oncology Associates at Mercy Medical Center — Cedar Rapids, Iowa, United States
• Medical Oncology and Hematology Associates-Des Moines — Des Moines, Iowa, United States
• Eastern Maine Medical Center — Bangor, Maine, United States
• Anne Arundel Medical Center — Annapolis, Maryland, United States
• Walter Reed National Military Medical Center — Bethesda, Maryland, United States
• Meritus Medical Center — Hagerstown, Maryland, United States
• Lowell General Hospital — Lowell, Massachusetts, United States
• Henry Ford Hospital — Detroit, Michigan, United States
• St. Joseph Mercy Ann Arbor Hospital — Ypsilanti, Michigan, United States
• Mayo Clinic — Rochester, Minnesota, United States
• Metro Minnesota Community Oncology Research Consortium — Saint Louis Park, Minnesota, United States
• Mercy Clinic Cancer and Hematology - Chub O'Reilly Cancer Center — Springfield, Missouri, United States
• Cox Medical Center South — Springfield, Missouri, United States
• Missouri Baptist Medical Center — St Louis, Missouri, United States
• Billings Clinic Cancer Center — Billings, Montana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.